Category: Medical

New Allograft Joins Market Leading ExoFlo™ Extracellular Vesicles in Direct Biologics Product Line

The expanded Access Program provides a pathway for patients to gain access to treatment with ExoFlo outside of the active Phase II research clinical trial.